The anti-aggregative peptide klvff mimics a1-40 in the modulation of nicotinic receptors: implications for peptide-based therapy

HIGHLIGHTS

  • who: Hanna Trebesova et al. from the Department of Pharmacy, Section of Pharmacology and Toxicology, University of Genoa, Genoa, Italy have published the research work: The Anti-Aggregative Peptide KLVFF Mimics A1-40 in the Modulation of Nicotinic Receptors: Implications for Peptide-Based Therapy, in the Journal: Biomedicines 2022, 2231 of /2022/
  • what: Regarding the properties of the Au03b2 peptides that the authors used in the study , the authors previously showed that under the experimental conditions, the solutions of Au03b2 were mainly formed from Au03b2 monomers.
  • future: Studies are needed to investigate the . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?